
Cordis
Cordis is a global leader of interventional cardiovascular technologies. From the first guidewire to the first drug eluting stent, for over 60 years Cordis (including Cordis USA, Cordis EMEA, Cordis LATAM and Cordis APAC) has remained at the heart of cardiovascular innovation. Cordis is again at the forefront of transformation in the cardiovascular space, leveraging internal development, partnership with the CordisX innovation incubator and targeted acquisitions of industry-disrupting technology. These innovations, brought to market with the strength of Cordis’ global footprint and operations, seek to transform the interventional space through enhanced clinical outcomes, customer-centric services, and impactful educational platforms – doubling-down on our commitment to the interventional community. Cordis will Go Beyond, to relentlessly pursue our dedication to transform cardiovascular care.
Discover more on Cordis.com and on our social media:
LUMEN BY CORDIS, our Learning Management System for HCPs in the US: https://cordiscorp.csod.com/login/render.aspx?id=defaultclp
LinkedIn linkedin.com/company/1201/admin/dashboard
YouTube: www.youtube.com/@CordisUSA
Cordis
Deploy With Confidence: Safe and Effective Bioabsorbable Venous Closure Device
- 935 views
- July 9, 2024
- 5
Cordis
Thirteen Steps to Avoid Radial Artery Access Complications in Peripheral Arterial Interventions
- 1,130 views
- October 3, 2023
- 13
Cordis
Radial Peripheral Case Review (3/4): Left SFA Revascularization via Radial Artery Access
- 243 views
- March 23, 2023
- 2
Cordis
Radial Peripheral Case Review (2/4): Left Common Iliac Artery CTO with In-stent Restenosis via Radial Access
- 230 views
- March 23, 2023
- 1
Cordis
Radial Peripheral Case Review (1/4): Right Superficial Femoral Artery Chronic Total Occlusion via Left Radial Access Combined with Pedal Access
- 1,310 views
- March 15, 2023
- 16